2Torbicki A, Perrier A, Konstantinides S, et al. Guide- lines on the diagnosis and management of acute pulmo- nary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the Euro- pean Society of Cardiology (ESC). Eur Heart J, 2008, 29 : 2276-2315.
3Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, il- iofemoral deep vein thrombosis, and chronic thromboem- bolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation, 2011, 123: 1788-1830.
4Goldhaber SZ. Thrombolysis for pulmonary embolism. N Engl J Med, 2002, 347: 1131-1132.
5Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med, 2002, 347: 1143-1150.
6Berghaus TM, Thilo C, Bluethgen A, et al. Effective- ness of thrombolysis in patients with intermediate-risk pulmonary embolism: influence on length of hospital stay. Adv Ther, 2010, 27: 648-654.
7Fasullo S, Scalzo S, Maringhini G, et al. Six-month echocardiographic study in patients with submassive pul- monary embolism and right ventricle dysfunction: corn-parison of thrombolysis with heparin. Am J Med Sei, 2011, 341: 33-39.
8Niwa A, Nakamura M, Harada N, et al. Observational investigation of thrombolysis with the tissue-type plas- minogen activator monteplase for acute pulmonary embol- ism in Japan. Cire J, 2012, 76: 2471-2480.
9Kline JA, Steuerwald MT, Marehiek MR, et al. Pro- speetive evaluation of right ventrieular function and func- tional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent eleva- tion in estimated pulmonary artery pressure. Chest, 2009, 136: 1202-1210.
10Zhang Y, Sun T, He B, et al. Thrombolytie therapy with urokinase for pulmonary embolism in patients with stable hemodynamies. Med Sei Monit, 2007, 13: CR20-23.
